Evidence map›Paper›PMID 36171012›Full record

ArticleBMJ case reports2022

Male infant with Noonan syndrome with

Mao Hagino, Chiharu Ota, Takehiko Onoki, Shinya Iwasawa

Open access · hybridAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Observational
  3. RASopathies and cardiac manifestations.Frontiers in cardiovascular medicine · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Mao HaginoDepartment of Paediatrics, Tohoku University Hospital, Sendai, Japan.
Chiharu OtaDepartment of Paediatrics, Tohoku University Hospital, Sendai, Japan chiharu.ota.e8@tohoku.ac.jp.ORCID http://orcid.org/0000-0002-0644-1144
Takehiko OnokiDepartment of Paediatrics, Tohoku University Hospital, Sendai, Japan.
Shinya IwasawaDepartment of Paediatrics, Tohoku University Hospital, Sendai, Japan.
Tohoku University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Noonan syndrome (NS) is a congenital disease with characteristic facial features as well as heart disease, short stature and thoracic abnormalities. More than eighty per cent of patients with NS show several cardiac disorders including pulmonary valvular stenosis, hypertrophic cardiomyopathy (HCM) and/or atrial septal defects. HCM is a serious cardiac comorbidity in patients with NS, especially in those who are diagnosed within 6 months of age with congestive heart failure. Arrhythmia with or without HCM in NS is a rare comorbidity with a complicated clinical course and poor prognosis.In this manuscript, we present the case of a male infant with NS with

Indexed as

AmiodaroneCardiomyopathy, HypertrophicHeart FailureNoonan SyndromeArrhythmias, CardiacFlecainideHumansInfantMaleMutationAmiodaroneFlecainideArrhythmiasHeart failurePaediatrics (drugs and medicines)

Identifiers

PMID36171012
PMCPMC9528629
OpenAlexW4297473173

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.